Siddharth Mahesh Patel, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Shock, Cardiogenic | 6 | 2024 | 709 | 2.310 |
Why?
|
Coronary Care Units | 4 | 2024 | 235 | 1.180 |
Why?
|
Atrial Fibrillation | 5 | 2024 | 5127 | 1.030 |
Why?
|
Hemorrhage | 5 | 2024 | 3424 | 0.990 |
Why?
|
Coronary Occlusion | 3 | 2017 | 304 | 0.950 |
Why?
|
Factor XI | 1 | 2024 | 34 | 0.920 |
Why?
|
Stroke | 5 | 2024 | 9758 | 0.790 |
Why?
|
Registries | 6 | 2024 | 8225 | 0.760 |
Why?
|
Troponin T | 2 | 2024 | 780 | 0.750 |
Why?
|
Cardiology | 2 | 2022 | 1656 | 0.750 |
Why?
|
Glucosides | 1 | 2024 | 512 | 0.640 |
Why?
|
Hospital Mortality | 5 | 2024 | 5293 | 0.610 |
Why?
|
Anticoagulants | 5 | 2024 | 4812 | 0.550 |
Why?
|
Lactones | 1 | 2019 | 317 | 0.540 |
Why?
|
Ischemia | 1 | 2021 | 1884 | 0.410 |
Why?
|
Secondary Prevention | 1 | 2019 | 1475 | 0.410 |
Why?
|
Heart Failure | 4 | 2024 | 11671 | 0.410 |
Why?
|
Catheters | 1 | 2015 | 427 | 0.390 |
Why?
|
Aortic Valve | 1 | 2021 | 1955 | 0.390 |
Why?
|
Warfarin | 3 | 2024 | 1483 | 0.360 |
Why?
|
Proteomics | 1 | 2024 | 3848 | 0.360 |
Why?
|
Critical Care | 4 | 2024 | 2697 | 0.360 |
Why?
|
Acute Coronary Syndrome | 1 | 2022 | 2190 | 0.340 |
Why?
|
Aortic Valve Stenosis | 1 | 2021 | 2001 | 0.330 |
Why?
|
Referral and Consultation | 1 | 2021 | 3600 | 0.310 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2015 | 1725 | 0.300 |
Why?
|
Peripheral Arterial Disease | 1 | 2019 | 1273 | 0.290 |
Why?
|
Pyridines | 1 | 2019 | 2875 | 0.280 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 2751 | 0.280 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2024 | 1723 | 0.250 |
Why?
|
Thrombosis | 1 | 2019 | 2942 | 0.240 |
Why?
|
Risk Assessment | 6 | 2024 | 23996 | 0.230 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2024 | 198 | 0.210 |
Why?
|
Peptide Fragments | 2 | 2024 | 5112 | 0.190 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15502 | 0.180 |
Why?
|
Prognosis | 4 | 2024 | 29629 | 0.170 |
Why?
|
Lipid Regulating Agents | 1 | 2019 | 21 | 0.170 |
Why?
|
Humans | 24 | 2024 | 761596 | 0.170 |
Why?
|
Critical Pathways | 1 | 2022 | 474 | 0.160 |
Why?
|
Hypotension | 1 | 2024 | 879 | 0.150 |
Why?
|
Treatment Outcome | 5 | 2024 | 64685 | 0.150 |
Why?
|
Aged | 9 | 2024 | 169310 | 0.150 |
Why?
|
Angiography | 1 | 2022 | 1595 | 0.140 |
Why?
|
Benzhydryl Compounds | 1 | 2024 | 916 | 0.140 |
Why?
|
Hypertriglyceridemia | 1 | 2019 | 293 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10212 | 0.130 |
Why?
|
Body Mass Index | 2 | 2024 | 12953 | 0.130 |
Why?
|
Male | 13 | 2024 | 360846 | 0.130 |
Why?
|
Administration, Oral | 1 | 2024 | 4021 | 0.130 |
Why?
|
Eicosapentaenoic Acid | 1 | 2019 | 561 | 0.130 |
Why?
|
Middle Aged | 9 | 2024 | 220921 | 0.120 |
Why?
|
Postoperative Complications | 1 | 2017 | 15633 | 0.120 |
Why?
|
Female | 13 | 2024 | 392705 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3124 | 0.120 |
Why?
|
Radiation Protection | 1 | 2018 | 424 | 0.120 |
Why?
|
Time Factors | 3 | 2024 | 39969 | 0.110 |
Why?
|
Hemodynamics | 1 | 2023 | 4160 | 0.110 |
Why?
|
Body Weight | 1 | 2024 | 4618 | 0.110 |
Why?
|
Saphenous Vein | 1 | 2015 | 516 | 0.100 |
Why?
|
Graft Occlusion, Vascular | 1 | 2015 | 537 | 0.100 |
Why?
|
Chronic Disease | 2 | 2017 | 9319 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2018 | 1189 | 0.090 |
Why?
|
Risk Factors | 5 | 2021 | 74213 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2024 | 2242 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2024 | 80647 | 0.080 |
Why?
|
Echocardiography | 1 | 2021 | 4989 | 0.080 |
Why?
|
Drug-Eluting Stents | 1 | 2015 | 681 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2022 | 3744 | 0.080 |
Why?
|
Occupational Exposure | 1 | 2018 | 1813 | 0.070 |
Why?
|
Equipment Design | 1 | 2015 | 3511 | 0.070 |
Why?
|
Case-Control Studies | 1 | 2024 | 22176 | 0.070 |
Why?
|
Phenotype | 1 | 2024 | 16592 | 0.070 |
Why?
|
Coronary Angiography | 2 | 2015 | 4471 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2019 | 11461 | 0.070 |
Why?
|
Forecasting | 1 | 2015 | 2928 | 0.070 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58984 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15843 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2019 | 3407 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3889 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26129 | 0.050 |
Why?
|
Lactates | 1 | 2023 | 405 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18399 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 12947 | 0.050 |
Why?
|
Vascular Resistance | 1 | 2023 | 930 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12149 | 0.040 |
Why?
|
Texas | 1 | 2015 | 404 | 0.030 |
Why?
|
Radial Artery | 1 | 2015 | 187 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1112 | 0.030 |
Why?
|
Canada | 1 | 2018 | 2122 | 0.030 |
Why?
|
Triglycerides | 1 | 2019 | 2461 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 2018 | 1121 | 0.020 |
Why?
|
Femoral Artery | 1 | 2015 | 826 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2015 | 1204 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 21355 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2015 | 2115 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2015 | 2188 | 0.020 |
Why?
|
Reoperation | 1 | 2015 | 4303 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12723 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39106 | 0.010 |
Why?
|
United States | 1 | 2018 | 72340 | 0.010 |
Why?
|